D

Dextrose and Electrolyte No. 48

5% Dextrose and Electrolyte No. 48 Injection (Multiple Electrolytes and Dextrose Injection, Type 1, USP) is a sterile, nonpyrogenic solution for fluid and electrolyte replenishment and caloric supply in a single dose container for intravenous administration. Each 100 mL contains… Continue Reading →

Desogen

DESOGEN Tablets (desogestrel and ethinyl estradiol tablets USP) provides an oral contraceptive regimen of 21 white round tablets each containing 0.15 mg desogestrel (13-ethyl-11-methylene-18,19-dinor-17 alpha-pregn-4-en-20-yn-17-ol) and 0.03 mg ethinyl estradiol (19-nor-17 alpha-pregna-1,3,5 (10)-trien-20-yne-3,17-diol). Inactive ingredients include vitamin E, corn starch,… Continue Reading →

Dopamine Hydrochloride

Fliptop Vial Pintop Vial MUST BE DILUTED PRIOR TO ADMINISTRATION Dopamine, a sympathomimetic amine vasopressor, is the naturally occurring immediate precursor of norepinephrine. Dopamine hydrochloride is a white to off-white crystalline powder, which may have a slight odor of hydrochloric… Continue Reading →

Diclofenac Sodium topical solution

Diclofenac Sodium topical solution, 1.5% w/w is a nonsteroidal anti-inflammatory drug, available as a clear, colorless to faintly pink-orange solution for topical application. Diclofenac Sodium topical solution contains 1.5% w/w of diclofenac sodium, a benzeneacetic acid derivative that is a… Continue Reading →

Dolotranz

Lidocaine 2.5% and Prilocaine 2.5% Cream, USP is an emulsion in which the oil phase is a eutectic mixture of lidocaine and prilocaine cream in a ratio of 1:1 by weight. This eutectic mixture has a melting point below room… Continue Reading →

DARZALEX

Daratumumab is an immunoglobulin G1 kappa (IgG1κ) human monoclonal antibody against CD38 antigen, produced in a mammalian cell line (Chinese Hamster Ovary [CHO]) using recombinant DNA technology. The molecular weight of daratumumab is approximately 148 kDa. DARZALEX is supplied as… Continue Reading →

Dexmethylphenidate Hydrochloride Extended-Release

Dexmethylphenidate Hydrochloride Extended-release Capsules is an Extended-release formulation of dexmethylphenidate with a bi-modal release profile. Each bead-filled Dexmethylphenidate Hydrochloride Extended-release capsules contains half the dose as immediate-release beads and half as enteric-coated, delayed-release beads, thus providing an immediate release of… Continue Reading →

Darifenacin Hydrobromide

Darifenacin Hydrobromide Extended-Release Tablets are an extended-release tablet for oral administration which contains 7.5 mg or 15 mg darifenacin as its hydrobromide salt. The active moiety, darifenacin, is a potent muscarinic receptor antagonist. Chemically, darifenacin hydrobromide is -2-{1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidinyl}-2,2-diphenylacetamide hydrobromide. The… Continue Reading →